- Industry Biotechnology
- Sector Healthcare
- Market Cap 1.14B
California, United States
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Travere Therapeutics expects FY22 revenue to be in line with consensus
- Travere Therapeutics GAAP EPS of -$1.09 misses by $0.17, revenue of $53.5M misses by $1.26M
- Travere Therapeutics Q3 2022 Earnings Preview
- Travere Therapeutics' FDA target action date for nephropathy treatment extended
- Travere, CSL kidney disease drug sparsentan gets review in EU
- Travere Therapeutics GAAP EPS of -$1.05 misses by $0.14, revenue of $54.2M beats by $4.7M
- Travere Theraspeutics a new buy at Canaccord as a 'rare disease powerhouse'
- Travere gains as FDA accepts marketing application for rare kidney disease therapy
- Travere Therapeutics falls 7% as analyst cuts price target
- Travere Therapeutics Non-GAAP EPS of $0.82 beats by $1.55, revenue of $48.5M misses by $3.42M
- Travere Therapeutics Q1 2022 Earnings Preview
- Travere Therapeutics CFO Laura Clague to retire
- Travere prices upsized $275M convertible senior notes offering
- Travere Therapeutics to raise $250M in senior notes offering
- Travere Therapeutics Non-GAAP EPS of -$0.61 misses by $0.11, revenue of $57.25M beats by $0.85M
- Travere Therapeutics Q4 2021 Earnings Preview
- Travere Therapeutics sees FY2021 revenue above consensus
- Travere Therapeutics gets new chief medical oficer
- Travere down 2% despite positive early-stage data for rare inherited disease therapy
- Travere Therapeutics EPS beats by $0.35, beats on revenue
|Date||EPS / Forecast||Revenue / Forecast|
|February 24, 2022||-0.84 / -0.6929||54.58M / 55.87M|
|October 28, 2021||-0.59 / -0.5617||68.22M / 60.93M||
|July 29, 2021||-0.64 / -0.62||54.62M / 50.33M||
|May 6, 2021||-0.96 / -0.4717||47.41M / 50.09M|
|March 1, 2021||-2.37 / -0.4256||50.98M / 51.66M|
|November 5, 2020||-0.44 / -0.5157||51.14M / 47.84M||
|July 30, 2020||-0.58 / -0.51||48.43M / 47.08M||
|May 11, 2020||-0.2 / -0.56||47.77M / 43.43M||